Multi-country evaluation of the durability of pyrethroid plus piperonyl-butoxide insecticide-treated nets: study protocol.
Durability
Insecticide-treated nets
MAGNet®
Olyset® plus
Piperonyl-butoxide
Tsara® Boost
Veeralin®
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
27 Jan 2023
27 Jan 2023
Historique:
received:
01
08
2022
accepted:
20
01
2023
entrez:
28
1
2023
pubmed:
29
1
2023
medline:
1
2
2023
Statut:
epublish
Résumé
Mass distributions of long-lasting insecticidal nets (LLINs) have contributed to large reductions in the malaria burden. However, this success is in jeopardy due in part to the increasing pyrethroid-resistant mosquito population as well as low LLINs coverage in various areas because the lifespan of LLINs is often shorter than the interval between replenishment campaigns. New insecticide-treated nets (ITNs) containing pyrethroid and piperonyl-butoxide (PBO) have shown a greater reduction in the incidence of malaria than pyrethroid LLINs in areas with pyrethroid-resistant mosquitoes. However, the durability (attrition, bio-efficacy, physical integrity and chemical retainment) of pyrethroid-PBO ITNs under operational settings has not been fully characterized. This study will measure the durability of pyrethroid-PBO ITNs to assess whether they meet the World Health Organization (WHO) three years of operational performance criteria required to be categorized as "long-lasting". A prospective household randomized controlled trial will be conducted simultaneously in Tanzania, India and Côte d'Ivoire to estimate the field durability of three pyrethroid-PBO ITNs (Veeralin®, Tsara® Boost, and Olyset® Plus) compared to a pyrethroid LLIN: MAGNet®. Durability monitoring will be conducted up to 36 months post-distribution and median survival in months will be calculated. The proportion of ITNs: (1) lost (attrition), (2) physical integrity, (3) resistance to damage score, (4) meeting WHO bio-efficacy (≥ 95% knockdown after 1 h or ≥ 80% mortality after 24 h for WHO cone bioassay, or ≥ 90% blood-feeding inhibition or ≥ 80% mortality after 24 h for WHO Tunnel tests) criteria against laboratory-reared resistant and susceptible mosquitoes, and insecticidal persistence over time will be estimated. The non-inferiority of Veeralin® and Tsara® Boost to the first-in-class, Olyset® Plus will additionally be assessed for mortality, and the equivalence of 20 times washed ITNs compared to field aged ITNs will be assessed for mortality and blood-feeding inhibition endpoints in the Ifakara Ambient Chamber Test, Tanzania. This will be the first large-scale prospective household randomized controlled trial of pyrethroid-PBO ITNs in three different countries in East Africa, West Africa and South Asia, simultaneously. The study will generate information on the replenishment intervals for PBO nets.
Sections du résumé
BACKGROUND
BACKGROUND
Mass distributions of long-lasting insecticidal nets (LLINs) have contributed to large reductions in the malaria burden. However, this success is in jeopardy due in part to the increasing pyrethroid-resistant mosquito population as well as low LLINs coverage in various areas because the lifespan of LLINs is often shorter than the interval between replenishment campaigns. New insecticide-treated nets (ITNs) containing pyrethroid and piperonyl-butoxide (PBO) have shown a greater reduction in the incidence of malaria than pyrethroid LLINs in areas with pyrethroid-resistant mosquitoes. However, the durability (attrition, bio-efficacy, physical integrity and chemical retainment) of pyrethroid-PBO ITNs under operational settings has not been fully characterized. This study will measure the durability of pyrethroid-PBO ITNs to assess whether they meet the World Health Organization (WHO) three years of operational performance criteria required to be categorized as "long-lasting".
METHODS
METHODS
A prospective household randomized controlled trial will be conducted simultaneously in Tanzania, India and Côte d'Ivoire to estimate the field durability of three pyrethroid-PBO ITNs (Veeralin®, Tsara® Boost, and Olyset® Plus) compared to a pyrethroid LLIN: MAGNet®. Durability monitoring will be conducted up to 36 months post-distribution and median survival in months will be calculated. The proportion of ITNs: (1) lost (attrition), (2) physical integrity, (3) resistance to damage score, (4) meeting WHO bio-efficacy (≥ 95% knockdown after 1 h or ≥ 80% mortality after 24 h for WHO cone bioassay, or ≥ 90% blood-feeding inhibition or ≥ 80% mortality after 24 h for WHO Tunnel tests) criteria against laboratory-reared resistant and susceptible mosquitoes, and insecticidal persistence over time will be estimated. The non-inferiority of Veeralin® and Tsara® Boost to the first-in-class, Olyset® Plus will additionally be assessed for mortality, and the equivalence of 20 times washed ITNs compared to field aged ITNs will be assessed for mortality and blood-feeding inhibition endpoints in the Ifakara Ambient Chamber Test, Tanzania.
CONCLUSION
CONCLUSIONS
This will be the first large-scale prospective household randomized controlled trial of pyrethroid-PBO ITNs in three different countries in East Africa, West Africa and South Asia, simultaneously. The study will generate information on the replenishment intervals for PBO nets.
Identifiants
pubmed: 36707886
doi: 10.1186/s12936-023-04465-x
pii: 10.1186/s12936-023-04465-x
pmc: PMC9881340
doi:
Substances chimiques
Piperonyl Butoxide
LWK91TU9AH
Pyrethrins
0
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
30Informations de copyright
© 2023. The Author(s).
Références
Insects. 2022 Jun 21;13(7):
pubmed: 35886738
Parasit Vectors. 2022 Apr 11;15(1):124
pubmed: 35410250
PLoS Med. 2020 Sep 18;17(9):e1003248
pubmed: 32946451
Malar J. 2021 Jan 19;20(1):45
pubmed: 33468114
Med Vet Entomol. 2000 Mar;14(1):1-5
pubmed: 10759305
Health Policy Plan. 2006 Jan;21(1):1-9
pubmed: 16301306
Cochrane Database Syst Rev. 2021 May 24;5:CD012776
pubmed: 34027998
Infect Dis Poverty. 2021 Dec 20;10(1):135
pubmed: 34930459
Malar J. 2007 Jan 25;6:10
pubmed: 17254339
Malar J. 2015 Aug 28;14:332
pubmed: 26310788
Insects. 2021 Dec 21;13(1):
pubmed: 35055850
Curr Res Parasitol Vector Borne Dis. 2022 May 25;2:100092
pubmed: 35734077
BMC Public Health. 2014 Dec 13;14:1266
pubmed: 25495268
Malar J. 2021 Jan 7;20(1):26
pubmed: 33413388
Malar J. 2019 Jul 4;18(1):224
pubmed: 31272452
Malar J. 2017 Aug 17;16(1):342
pubmed: 28818077
Am J Trop Med Hyg. 2019 Aug;101(2):371-382
pubmed: 31264562
Parasitol Today. 1985 Nov;1(5):147-8
pubmed: 15275589
Malar J. 2021 Mar 29;20(1):171
pubmed: 33781261
Malar J. 2021 Jan 7;20(1):29
pubmed: 33413383
Malar J. 2014 Sep 01;13:344
pubmed: 25174414
Malar J. 2011 Oct 13;10:299
pubmed: 21992483
Malar J. 2015 Mar 24;14:123
pubmed: 25890233
Nat Commun. 2021 Jun 11;12(1):3589
pubmed: 34117240
Malar J. 2020 Aug 28;19(1):310
pubmed: 32859210
Malar J. 2020 May 24;19(1):187
pubmed: 32448313
Malar J. 2021 Jan 19;20(1):47
pubmed: 33468152
Malar J. 2019 Dec 23;18(1):441
pubmed: 31870365
Trans R Soc Trop Med Hyg. 1992 Jul-Aug;86(4):362-4
pubmed: 1440802
Insects. 2022 May 06;13(5):
pubmed: 35621770
Insect Mol Biol. 1998 May;7(2):179-84
pubmed: 9535162
Malar J. 2014 Nov 27;13:464
pubmed: 25430956
Malar J. 2019 Apr 30;18(1):153
pubmed: 31039788
Malar J. 2010 Jul 22;9:211
pubmed: 20663143
Malar J. 2020 Jun 23;19(1):220
pubmed: 32576180
Nature. 2015 Oct 8;526(7572):207-211
pubmed: 26375008
Parasit Vectors. 2014 Jan 04;7:6
pubmed: 24387635
Am J Trop Med Hyg. 2012 Sep;87(3):407-411
pubmed: 22802441
Insect Biochem Mol Biol. 2004 Jul;34(7):653-65
pubmed: 15242706
Lancet. 2018 Apr 21;391(10130):1577-1588
pubmed: 29655496
Cochrane Database Syst Rev. 2018 Nov 29;11:CD012776
pubmed: 30488945
Trends Parasitol. 2021 Jul;37(7):610-621
pubmed: 33773912
Am J Trop Med Hyg. 2003 Apr;68(4 Suppl):121-7
pubmed: 12749495
Lancet. 1986 Jul 26;2(8500):204-7
pubmed: 2873448
Health Policy Plan. 2006 Nov;21(6):459-68
pubmed: 17030551
Malar J. 2021 Jan 19;20(1):46
pubmed: 33468151